cerecor-logo-final.png
Cerecor Announces First Patient Enrolled in CDG FIRST Trial
July 15, 2019 06:30 ET | Cerecor Inc.
ROCKVILLE, Md., July 15, 2019 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for rare...
cerecor-logo-final.png
Cerecor Announces Positive Final Results of CERC-301 in the Treatment of Neurogenic Orthostatic Hypotension (OH)
July 01, 2019 06:30 ET | Cerecor Inc.
ROCKVILLE, Md., July 01, 2019 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for rare...
cerecor-logo-final.png
Cerecor Added to Russell 3000® Index
June 28, 2019 06:30 ET | Cerecor Inc.
ROCKVILLE, Md., June 28, 2019 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for rare...
cerecor-logo-final.png
Cerecor Appoints Keith Schmidt to its Board of Directors
June 12, 2019 16:05 ET | Cerecor Inc.
ROCKVILLE, Md., June 12, 2019 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for rare...
cerecor-logo-final.png
Cerecor Set to Join Russell 3000® Index
June 11, 2019 13:00 ET | Cerecor Inc.
ROCKVILLE, Md., June 11, 2019 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for rare...
cerecor-logo-final.png
Cerecor Reports First Quarter 2019 Results
May 09, 2019 16:05 ET | Cerecor Inc.
- Positive interim results from the Phase l study of CERC-301 in nOH -Positive results from Phase I Safety Data for CERC-801 in Healthy Volunteers ROCKVILLE, Md., May 09, 2019 (GLOBE NEWSWIRE) --...
cerecor-logo-final.png
Cerecor Announces Positive Phase I Safety Data for CERC-801 in Healthy Volunteers
April 29, 2019 06:30 ET | Cerecor Inc.
ROCKVILLE, Md., April 29, 2019 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for rare...